Amulet Capital Partners, a middle-market private equity investment firm based in Greenwich, CT, focused exclusively on the healthcare sector, announced today tit closed a second fund, Amulet Capital Partners II. The fund was oversubscribed and closed with in excess of $650 million in capital commitments, exceeding the target of $500 million.
The fund has already completed two investments, US Fertility, a physician practice management company serving the fertility market in the US, and SSI Strategy, a consulting firm focused on providing medical affairs and clinical development support to emerging biotech companies.
This fundraise brings Amulet’s total regulatory capital under management to over $1.3 billion. Read more.
